Alimta

... Research and Markets: Analysis of Oncology Within Large Pharmaceutical Companies and How Far It Has Gone Research and Markets: Analysis of Oncology Within Large Pharmaceutical Companies and How Far It Has Gone Research and Markets logo.

(PRNewsFoto) LONDON XEN 08/20/2004 DUBLIN, Ireland, April 27 /PRNewswire/ - Research and Markets (http://www.researchandmarkets.com/reports/c16539 ) has announced the addition of Business Development and R&D Database: Oncology in Big Pharma to their offering.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040820/RESEARCH ) This unique CD-ROM database was compiled to enable your independent and unbiased analysis.

By using this database you will be able to gain knowledge about the progress made by the large pharmaceutical companies in the field of oncology.

This database provides more than 10 000 records carefully identified and defined in several subcategories (see below).

All records included are associated to cancer therapeutic projects related to the large pharmaceutical industry.

This exclusive database provides you with an update on the most recent advances made as well as a historical view demonstrating the competitive struggle that exists between the large pharmaceutical companies.

The searchable database will also provide information about pitfalls as well as competition and business opportunities in the oncology field.

The information in the database has carefully been selected and structured to provide the...

... Research and Markets: Providing Update Information on the Most Recent Advances Made and the Competitive Struggle That Exists Between the Large Pharmaceutical Companies Research and Markets: Providing Update Information on the Most Recent Advances Made and the Competitive Struggle That Exists Between the Large Pharmaceutical Companies Research and Markets logo.

(PRNewsFoto) LONDON XEN 08/20/2004 DUBLIN, Ireland, April 27 /PRNewswire/ - Research and Markets (http://www.researchandmarkets.com/reports/c16537 ) has announced the addition of Large Pharma: 2004 A Year of Progress to their offering.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040820/RESEARCH ) The gross majority of all drugs, which reach late stage of development, are someway or another passed on to the large pharmaceutical companies because they hold the capital needed to conduct the expensive clinical trials as well as the regulatory commitment needed to gain an approval.

In this report progress is analysed that is made by the large pharmaceutical companies top oncology drug candidates whom have reached Phase III clinical evaluation.

This report provides you with update information on the most recent advances made and the competitive struggle that exists between the large pharmaceutical companies.

Hallmarks of 2004 includes that BAY 43-9006 and CCI-779 were granted Fast Track Designition for treating patients with renal cell carcinoma.

Fast Track Designition were also awarded to Xcytri...

... Genta Shows Genasense Boosting Data - Forbes.com '); } if( partner == 'netscape' ) { document.write(''); } if (document.cookie.indexOf('partner_session=earthlink') !

= -1) { document.write(''); } if (document.cookie.indexOf('partner_session=msnbc') !

= -1) { var _rsCI='us-forbes'; var _rsCG='msnbc_hat_test'; var _rsDT=1; var _rsSI=escape(window.location); var _rsLP=location.protocol.indexOf('https')=4) { var _rsRD=(new Date()).getTime(); var _rsSE=1; var _rsSV=''; var _rsSM=1.0; _rsCL=''; } else { _rsCL=''; } //document.write(_rsCL); document.write(''); } if (document.cookie.indexOf('partner_session=compuserve') !

= -1) { document.write(''); } // -> Jump | Free Trial Issue Search Quote Select Section Home Investment Newsletters Polls & Discussions Premium Tools Special Reports Video & Audio Watchlist IT Research Library IT Product & Service Search Forbes Digital Tool Business -Manufacturing -Technology -Commerce -Services -Energy -Healthcare -Small Business Technology -E-Business -Enterprise Tech -Infoimaging -Intelligent Infrastructure -Personal Tech -Sciences & Medicine -Wireless -CIO Network Markets -Equities -Economy -Commodities -Bonds -Emerging Markets -Currencies Work -Careers -Compensation -Entrepreneurs -Management Lists -Companies -Forbes 500s -Forbes Global 500 -200 Best Small Cos.

-400 Best Big Cos.

-Larges...